Atlas Trials

A Study of CM310 in Subjects With Moderate to Severe Asthma

Clinical trial NCT05186909 · COMPLETED

Trial details

NCT number
NCT05186909
Sponsor
Keymed Biosciences Co.Ltd
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma
Start date
2022-01-12
Primary completion
2023-09-13
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.